EXTON, Pa., May 26, 2011 /PRNewswire/ -- Kensey Nash Corporation (Nasdaq: KNSY) announced today that it has entered intoa new $35 million unsecured revolving credit facility with Wells Fargo Bank, National Association.
The new credit facility has a term of three years, maturing on May 25, 2014, with the
"The availability of this new credit facility provides us the flexibility to be able to execute our growth plans at attractive rates and enhances our liquidity position," said Michael Celano, CFO of Kensey Nash.
About Kensey Nash Corporation. Kensey Nash Corporation is a medical device company primarily focused on regenerative medicine utilizing its proprietary collagen and synthetic polymer technology. The Company is recognized as a leader for innovative product development and unique technology in the field of resorbable biomaterials. The Company has an extensive range of products, which are sold through strategic partners in multiple medical markets, including the cardiology, orthopaedic, sports medicine, spine, endovascular and general surgery markets.
SOURCE Kensey Nash Corporation
Subscribe to our Free Newsletters!
Summer is a time for fun but the hot weather brings with it a host of diseases. With some health ...
Bacterial infection that causes inflammation of the membranes of the brain, is called bacterial ...
Liver disease that ends in liver failure (end stage liver disease), disrupting several important ...View All